79421-40-2

Usage

Uses

Used in Organic Synthesis:
4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)BENZENECARBALDEHYDE is utilized as a key intermediate in organic synthesis for the creation of various complex organic molecules. Its unique spiro ring system allows for the development of novel chemical entities with potential applications across different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)BENZENECARBALDEHYDE serves as a promising candidate for drug development. Its distinctive chemical structure may contribute to the design of innovative pharmaceutical products, although further research is necessary to explore its specific applications and properties in drug discovery and medicinal chemistry.
While the provided materials do not specify particular applications or industries for 4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)BENZENECARBALDEHYDE, the general uses outlined above are based on its classification and potential in organic synthesis and pharmaceutical research. Further investigation would be required to identify specific applications and industries where 4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)BENZENECARBALDEHYDE could be effectively utilized.

InChI:InChI=1/C14H17NO3/c16-11-12-1-3-13(4-2-12)15-7-5-14(6-8-15)17-9-10-18-14/h1-4,11H,5-10H2

Upstream product

• 459-57-4 4-fluorobenzaldehyde 
• 177-11-7 4,4-ethylenedioxy-piperidine 
• 1122-91-4 4-bromo-benzaldehyde 

Downstream Products

• 108122-59-4 8-[4-((E)-2-Nitro-propenyl)-phenyl]-1,4-dioxa-8-aza-spiro[4.5]decane 
• 391904-95-3 5-[1-[4-(1,4-Dioxa-8-aza-spiro[4.5]dec-8-yl)-phenyl]-meth-(Z)-ylidene]-thiazolidine-2,4-dione 
• 340756-80-1 (E)-3-[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)phenyl]acrylic acid ethyl ester 
• 349636-48-2 5-[4-(1,4-dioxa-8-aza-spiro[4.5]dec-8-yl)benzylidene]thiazolidine-2,4-dione 
• 349636-49-3 5-[4-(1,4-dioxa-8-aza-spiro[4.5]dec-8-yl)benzylidene]-2-iminothiazolidin-4-one 
• 344604-91-7 5-[4-(4-oxopiperidin-1-yl)benzyl]thiazolidine-2,4-dione 
• 349636-66-4 N-hydroxy-N-[4-(4-oxo-1-piperidinyl)benzyl]urea 
• 349636-68-6 2-[4-(4-oxo-1-piperidinyl)benzyl]-1,2,4-oxadiazolidine-3,5-dione 
• 349636-57-3 1-[4-(2-imino-4-oxothiazolidin-5-ylmethyl)phenyl]piperidin-4-one 
• 391905-17-2 N-[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)benzyl]-N-hydroxyurea 
• 349636-58-4 5-[4-(4-oxopiperidin-1-yl)benzyl]imidazolidine-2,4-dione 
• 349636-72-2 4-oxo-5-[4-(4-oxopiperidin-1-yl)benzylidene]-4,5-dihydrothiazol-2-yl-cyanamide 
• 349636-71-1 5-[4-(1,4-dioxa-8-aza-spiro[4.5]dec-8-yl)benzylidene]-2-methylsulfanylthiazo-4-one 
• 349636-75-5 N,N-dimethyl-N'-{4-oxo-5-[4-(4-oxopiperidin-1-yl)benzylidene]-4,5-dihydrothiazol-2-yl}guanidine 

Relevant academic research and scientific papers

An improved synthesis of N-aryl and N-heteroaryl substituted piperidones

An efficient Pd(0)-catalyzed protocol for the rapid and efficient preparation of N-aryl and N-heteroaryl substituted piperidones is described. The two step syntheses proceed with an overall yield of 50-70% using X-Phos as optimal ligand for the Pd(0)-cata

Phenylpiperidines and phenylpyrrolidines

Substituted phenylpiperidines and phenylpyrrolidines of formula (I), compositions containing them, and methods of making and using them to treat histamine-mediated conditions.